Found: 52
Select item for more details and to access through your institution.
First Reported Case of Invasive Cutaneous Penicillium cluniae Infection in a Patient With Acute Myelogenous Leukemia: A Case Report and Literature Review.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab265
- By:
- Publication type:
- Article
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3- ITD acute myeloid leukaemia in first complete remission.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 3, p. 496, doi. 10.1111/bjh.14260
- By:
- Publication type:
- Article
Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 9, p. E233, doi. 10.1002/ajh.27005
- By:
- Publication type:
- Article
Differentiation syndrome with lower‐intensity treatments for acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. 735, doi. 10.1002/ajh.26142
- By:
- Publication type:
- Article
Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable‐risk acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. E59, doi. 10.1002/ajh.26057
- By:
- Publication type:
- Article
Novel Treatment Advances and Approaches in Acute Myeloid Leukemia (AML): Expert Strategies for Improved Clinical and Economic Outcomes.
- Published in:
- Journal of Managed Care Medicine, 2020, v. 23, n. 1, p. 10
- By:
- Publication type:
- Article
Prognostic Significance of Residual Acute Myeloid Leukemia in Bone Marrow Samples Taken Prior to Allogeneic Hematopoietic Cell Transplantation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond.
- Published in:
- Therapeutic Advances in Hematology, 2014, v. 5, n. 3, p. 65, doi. 10.1177/2040620714532123
- By:
- Publication type:
- Article
Mutations in Epigenetic Modifiers in Myeloid Malignancies and the Prospect of Novel Epigenetic-Targeted Therapy.
- Published in:
- Advances in Hematology, 2012, p. 1, doi. 10.1155/2012/469592
- By:
- Publication type:
- Article
The role of FLT3 inhibitors in the treatment of FLT3-mutated acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 4, p. 330, doi. 10.1111/ejh.12841
- By:
- Publication type:
- Article
Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 5, p. 1, doi. 10.1002/ccr3.4115
- By:
- Publication type:
- Article
Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemia.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 496, doi. 10.1111/his.14726
- By:
- Publication type:
- Article
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. 674, doi. 10.1016/j.clml.2023.05.002
- By:
- Publication type:
- Article
MDS-335: Ivosidenib (IVO) in Patients with IDH1-Mutant Relapsed/Refractory Myelodysplastic Syndrome (R/R MDS): Updated Enrollment for the MDS Sub-Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S346, doi. 10.1016/S2152-2650(21)01805-X
- By:
- Publication type:
- Article
Poster: MDS-335: Ivosidenib (IVO) in Patients with IDH1-Mutant Relapsed/Refractory Myelodysplastic Syndrome (R/R MDS): Updated Enrollment for the MDS Sub-Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S230, doi. 10.1016/S2152-2650(21)01451-8
- By:
- Publication type:
- Article
Antibody-Based Therapy in AML: Antibody–Drug Conjugates and Bispecific Agents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S112, doi. 10.1016/S2152-2650(21)01231-3
- By:
- Publication type:
- Article
Acute Myeloid Leukemia: Historical Perspective and Progress in Research and Therapy Over 5 Decades.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 9, p. 580, doi. 10.1016/j.clml.2021.05.016
- By:
- Publication type:
- Article
Incidence of Invasive Fungal Infections in Acute Myeloid Leukemia Without Antifungal Prophylaxis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ivosidenib (IVO; AG-120) in IDH1-Mutant Relapsed or Refractory Myelodysplastic Syndrome: Updated Results from a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S340, doi. 10.1016/j.clml.2019.07.341
- By:
- Publication type:
- Article
Ivosidenib (IVO; AG-120) in IDH1-Mutant Newly-Diagnosed Acute Myeloid Leukemia (ND AML): Updated Results from a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S220, doi. 10.1016/j.clml.2019.07.094
- By:
- Publication type:
- Article
Mutant IDH1 Inhibitor Ivosidenib (IVO; AG-120) in Combination with Azacitidine (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S217, doi. 10.1016/j.clml.2019.07.090
- By:
- Publication type:
- Article
Ivosidenib (AG-120) in Mutant IDH1 Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S204, doi. 10.1016/j.clml.2018.07.057
- By:
- Publication type:
- Article
Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
New directions for emerging therapies in acute myeloid leukemia: the next chapter.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 10, p. 1, doi. 10.1038/s41408-020-00376-1
- By:
- Publication type:
- Article
Lenalidomide combined with mismatched microtransplantation for acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. E331, doi. 10.1002/ajh.25218
- By:
- Publication type:
- Article
Impact of lenalidomide use among non‐transfusion dependent patients with myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 9, p. 1119, doi. 10.1002/ajh.25166
- By:
- Publication type:
- Article
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 254, doi. 10.1002/ajh.24968
- By:
- Publication type:
- Article
Chromosome 17p deletion in a case of T-cell acute lymphoblastic lymphoma.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 3, p. 267, doi. 10.1002/ajh.23847
- By:
- Publication type:
- Article
Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 8, p. 642, doi. 10.1002/ajh.23462
- By:
- Publication type:
- Article
Pure erythroid leukemia evolving from a therapy-related myelodysplastic syndrome secondary to treatment for chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 240, doi. 10.1002/ajh.23224
- By:
- Publication type:
- Article
Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic Alterations.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 8, p. e2119812, doi. 10.1001/jamanetworkopen.2021.19812
- By:
- Publication type:
- Article
Dasatinib-Induced Gynecomastia in 2 Patients with Chronic Myeloid Leukemia: Case Reports and Review of the Literature.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 24
- By:
- Publication type:
- Article
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 3, p. 321, doi. 10.1007/s11523-024-01054-z
- By:
- Publication type:
- Article
Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population-based study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Health care utilization and end-of-life care for older patients with acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 16, p. 2840, doi. 10.1002/cncr.29430
- By:
- Publication type:
- Article
Trends in all-cause mortality among patients with chronic myeloid leukemia: A Surveillance, Epidemiology, and End Results database analysis.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Trends in all-cause mortality among patients with chronic myeloid leukemia Trends in all-cause mortality among patients with chronic myeloid leukemia: A Surveillance, Epidemiology, and End Results database analysis.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 14, p. 2620, doi. 10.1002/cncr.28106
- By:
- Publication type:
- Article
Hypereosinophilia in relapsed acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 1, p. 2, doi. 10.1111/j.1365-2141.2011.08804.x
- By:
- Publication type:
- Article
Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy.
- Published in:
- Oncologist, 2022, v. 27, n. 2, p. 82, doi. 10.1093/oncolo/oyab052
- By:
- Publication type:
- Article
Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma.
- Published in:
- Oncologist, 2016, v. 21, n. 2, p. 214, doi. 10.1634/theoncologist.2015-0342
- By:
- Publication type:
- Article
Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-Hydroxyglutarate.
- Published in:
- Oncologist, 2014, v. 19, n. 6, p. 602, doi. 10.1634/theoncologist.2013-0417
- By:
- Publication type:
- Article
FLT3 Inhibition as Therapy in Acute Myeloid Leukemia: A Record of Trials and Tribulations.
- Published in:
- Oncologist, 2011, v. 16, n. 8, p. 1162, doi. 10.1634/theoncologist.2011-0084
- By:
- Publication type:
- Article
Factors Associated with Health Care Utilization at the End of Life for Patients with Acute Myeloid Leukemia.
- Published in:
- Journal of Palliative Medicine, 2022, v. 25, n. 5, p. 749, doi. 10.1089/jpm.2021.0249
- By:
- Publication type:
- Article
Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 3425, doi. 10.2147/OTT.S141212
- By:
- Publication type:
- Article
Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1075, doi. 10.1002/cncr.34645
- By:
- Publication type:
- Article
Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 24, p. 4702, doi. 10.1002/cncr.33886
- By:
- Publication type:
- Article
Posttraumatic stress disorder symptoms in patients with acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 14, p. 2500, doi. 10.1002/cncr.33524
- By:
- Publication type:
- Article